Treatment failure in superficial basal cell carcinoma following treatment with photodynamic therapy: is this a result of underdiagnosis?

Journal of the European Academy of Dermatology and Venereology

Volumn 31, Issue 1, 2017, Pages e50-e52

  Hoogedoorn, L ^a   Hendriks, J C M ^a   Knuiman, G J ^a   Blokx, W A M ^a   van de Kerkhof, P C M ^a   van Erp, P E J ^a   Gerritsen, M J P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; AMINOLEVULINIC ACID; METHYL 5-AMINOLEVULINATE;

BASAL CELL CARCINOMA; CANCER RECURRENCE; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PUNCH BIOPSY; RETROSPECTIVE STUDY; SUPERFICIAL BASAL CELL CARCINOMA; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR BIOPSY; ANALOGS AND DERIVATIVES; CARCINOMA, BASAL CELL; PATHOLOGY; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

AMINOLEVULINIC ACID; CARCINOMA, BASAL CELL; HUMANS; PHOTOCHEMOTHERAPY; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT FAILURE;

EID: 84973294720     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13715     Document Type: Letter

References (10)

1. Russell EB, Carrington PR, Smoller BR. Basal cell carcinoma: a comparison of shave biopsy versus punch biopsy techniques in subtype diagnosis. J Am Acad Dermatol 1999; 41: 69–71.
2. Roozeboom MH, Mosterd K, Winnepenninckx VJ, Nelemans PJ, Kelleners-Smeets NW. Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma. J Eur Acad Dermatol Venereol 2013; 27: 894–898.
3. Wolberink EA, Pasch MC, Zeiler M, van Erp PE, Gerritsen MJ. High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases. J Eur Acad Dermatol Venereol 2013; 27: 985–989.
4. Mosterd K, Thissen MR, van Marion AM et al. Correlation between histologic findings on punch biopsy specimens and subsequent excision specimens in recurrent basal cell carcinoma. J Am Acad Dermatol 2011; 64: 323–327.
5. Arits AH, Mosterd K, Essers BA et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 2013; 14: 647–654.
6. Roozeboom MH, Arits AH, Nelemans PJ, Kelleners-Smeets NW. Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol 2012; 167: 733–756.
7. Fantini F, Greco A, Del Giovane C et al. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J Eur Acad Dermatol Venereol 2011; 25: 896–901.
8. Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol 2013; 27: 536–544.
9. Fiechter S, Skaria A, Nievergelt H, Anex R, Borradori L, Parmentier L. Facial basal cell carcinomas recurring after photodynamic therapy: a retrospective analysis of histological subtypes. Dermatology 2012; 224: 346–351.
10. Lang PG Jr, Maize JC. Histologic evolution of recurrent basal cell carcinoma and treatment implications. J Am Acad Dermatol 1986; 14: 186–196.